Cabaletta Bio Inc.

NASDAQ: CABA · Real-Time Price · USD
1.71
0.06 (3.64%)
At close: Aug 15, 2025, 3:59 PM
1.71
0.00%
After-hours: Aug 15, 2025, 07:52 PM EDT

Cabaletta Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 1.64M n/a n/a n/a 4.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
468K 485K 819K 424K 426K 393K 336K 355K 833K n/a 2.86M 363K 238K 219K 234K 221K 162K 116K
Gross Profit
-468K -485K 819K -424K -426K -393K 3.67M -355K -833K n/a -2.86M -363K -238K -219K -234K -221K -162K -116K
Operating Income
-45.91M -37.14M -33.78M -33.05M -30.28M -28.03M -23.15M -18.67M -15.89M -16.96M -16.3M -11.78M -13.06M -13M -13.89M -11.56M -11.14M -9.71M
Interest Income
1.41M 1.49M 1.95M 2.42M 2.68M 2.98M 2.26M 2.22M 1.4M 1.1M 610K 351K 150K 53K 5K 3K 6K 10K
Pretax Income
-45.13M -35.94M -32.59M -30.63M -27.6M -25.05M -20.89M -16.45M -14.49M -15.85M -15.69M -11.43M -12.91M -12.95M -13.89M -11.56M -11.14M -9.7M
Net Income
-45.13M -35.94M -32.59M -30.63M -27.6M -25.05M -20.89M -16.45M -14.49M -15.85M -14.88M -11.08M -12.76M -12.89M -13.89M -11.56M -11.14M -9.7M
Selling & General & Admin
8.27M 8.12M 8.65M 6.76M 6.85M 5.68M 5.41M 4.88M 4.09M 4.52M 3.9M 3.56M 3.55M 3.83M 3.97M 3.39M 3.29M 3.16M
Research & Development
37.64M 29.02M 25.53M 26.29M 23.43M 21.95M 17.41M 13.79M 11.8M 12.44M 12.4M 8.22M 9.51M 9.17M 9.92M 8.17M 7.85M 6.56M
Other Expenses
n/a n/a -393K n/a n/a n/a 336K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
45.91M 37.14M 33.78M 33.05M 30.28M 27.64M 23.15M 18.67M 15.89M 16.96M 16.3M 11.78M 13.06M 13M 13.89M 11.56M 11.14M 9.71M
Interest Expense
571K 294K 748K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 393K n/a n/a -393K -336K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
45.91M 37.14M 33.78M 33.05M 30.28M 28.03M 23.15M 18.67M 15.89M 16.96M 16.3M 11.78M 13.06M 13M 13.89M 11.56M 11.14M 9.71M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -813K -351K -150K -53K n/a n/a n/a n/a
Shares Outstanding (Basic)
61.88M 49.52M 50.13M 48.94M 48.94M 49.3M 44.44M 43.96M 39.17M 33.59M 29.45M 29.01M 28.99M 28.96M 28.34M 25.85M 20.42M 19.19M
Shares Outstanding (Diluted)
61.88M 49.47M 50.2M 49.47M 49.45M 49.3M 44.44M 43.96M 39.17M 35.45M 29.45M 29.01M 28.99M 28.96M 28.34M 25.85M 24.73M 23.76M
EPS (Basic)
-0.73 -0.73 -0.65 -0.63 -0.56 -0.5 -0.47 -0.37 -0.37 -0.45 -0.51 -0.38 -0.44 -0.45 -0.49 -0.45 -0.55 -0.51
EPS (Diluted)
-0.73 -0.73 -0.65 -0.62 -0.56 -0.51 -0.47 -0.37 -0.37 -0.42 -0.51 -0.38 -0.44 -0.45 -0.49 -0.45 -0.45 -0.41
EBITDA
-44.09M -37.14M -23.29M -32.62M -29.85M -27.64M -22.81M -18.31M -15.52M -16.59M -15.94M -11.41M -12.82M -12.78M -13.66M -11.34M -10.98M -9.6M
EBIT
-44.56M -35.65M -23.76M -33.05M -30.28M -28.03M -23.15M -18.67M -15.89M -16.96M -16.3M -11.78M -13.06M -13M -13.89M -11.56M -11.14M -9.71M
Depreciation & Amortization
468K 485K 468K 424K 426K 393K 336K 355K 833K 365K 2.86M 363K 238K 219K 234K 221K 162K 116K